These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 111881)

  • 1. Activation of the alternative pathway of human complement by haemoglobin.
    Wilson WA; Thomas EJ
    Clin Exp Immunol; 1979 Apr; 36(1):140-4. PubMed ID: 111881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma haemoglobin and complement activation in sickle cell disease.
    DeCeulaer K; Wilson WA; Morgan AG; Serjeant GR
    J Clin Lab Immunol; 1981 Jul; 6(1):57-60. PubMed ID: 7265176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of chrysotile asbestos fibres with the complement system.
    Saint-Remy JM; Cole P
    Immunology; 1980 Oct; 41(2):431-7. PubMed ID: 6904360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the alternative pathway of complement by human peripheral nerve myelin.
    Koski CL; Vanguri P; Shin ML
    J Immunol; 1985 Mar; 134(3):1810-4. PubMed ID: 2578522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Requirement for the alternative pathway as well as C4 and C2 in complement-dependent hemolysis via the lectin pathway.
    Suankratay C; Zhang XH; Zhang Y; Lint TF; Gewurz H
    J Immunol; 1998 Mar; 160(6):3006-13. PubMed ID: 9510205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the complement system and leukocyte recruitment by Tityus serrulatus scorpion venom.
    Bertazzi DT; de Assis-Pandochi AI; Talhaferro VL; Caleiro Seixas Azzolini AE; Pereira Crott LS; Arantes EC
    Int Immunopharmacol; 2005 Jun; 5(6):1077-84. PubMed ID: 15829423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of gangliosides on activation of the alternative pathway of human complement.
    Michalek MT; Bremer EG; Mold C
    J Immunol; 1988 Mar; 140(5):1581-7. PubMed ID: 3346542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement activating property of the protein-rich endotoxin (OEP) of Pseudomonas aeruginosa. I. Activation of both the classical and the alternative pathways of guinea pig complement.
    Inada K
    Jpn J Exp Med; 1980 Feb; 50(1):13-21. PubMed ID: 6770130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the alternative pathway of complement by antiserum to factor B.
    Wilson MR; Arroyave CM; Tan EM
    J Lab Clin Med; 1979 Mar; 93(3):493-8. PubMed ID: 107255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ; Ramsey J; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library.
    Sahu A; Kay BK; Lambris JD
    J Immunol; 1996 Jul; 157(2):884-91. PubMed ID: 8752942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of alternative pathway factor D by factor B-related synthetic hexapeptides.
    Lesavre P; Gaillard MH; Halbwachs-Mecarelli L
    Eur J Immunol; 1982 Mar; 12(3):252-4. PubMed ID: 6920299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the haemolytic activity of circulating C1q-C3/C4 complexes.
    Wouters D; Brouwer MC; Daha MR; Hack CE
    Mol Immunol; 2008 Apr; 45(7):1893-9. PubMed ID: 18054386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Formation of classical C3 convertase during the alternative pathway of human complement activation].
    Kozlov LV; Shibanova ED; Zinchenko AA
    Biokhimiia; 1987 Apr; 52(4):660-6. PubMed ID: 3647798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-covalently bound C3 enhances lysis of rabbit erythrocytes through the alternative pathway.
    Hidvégi T; Füst G; Rajnavölgyi E; Kulics J; Gergely J
    Immunology; 1985 Dec; 56(4):735-41. PubMed ID: 3935572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of C3 and factor B in patients with congenital factor I deficiency.
    Rasmussen JM; Teisner B; Brandt J; Brandslund I; Gry H
    J Clin Lab Immunol; 1990 Feb; 31(2):59-67. PubMed ID: 1966986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of human complement by heat-killed, human kidney cells grown in cell culture.
    Baker PJ; Osofsky SG
    J Immunol; 1980 Jan; 124(1):81-6. PubMed ID: 6765971
    [No Abstract]   [Full Text] [Related]  

  • 18. Lysis of horse red blood cells mediated by antibody-independent activation of the alternative pathway of chicken complement.
    Ohta H; Yoshikawa Y; Kai C; Yamanouchi K; Okada H
    Immunology; 1984 Jul; 52(3):437-44. PubMed ID: 6430791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Concentration-functional interrelationships in the human alternative complement activation pathway].
    Galebskaia LV; Shcherbak IG; Bel'tiukov PP; Riumina EV; Solovtsova IL
    Biokhimiia; 1993 Nov; 58(11):1796-800. PubMed ID: 8268316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assembly of the membrane attack complex promotes decay of the alternative pathway C3 convertase on Neisseria gonorrhoeae.
    Densen P; McRill CM; Ross SC
    J Immunol; 1988 Dec; 141(11):3902-9. PubMed ID: 3141507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.